The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intermittent or continuous panitumumab plus FOLFIRI (FOLFIRI/PANI) for first-line treatment of patients (pts) with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): An update of survival/toxicity and preliminary results of genomic alterations from IMPROVE study.
 
Antonio Avallone
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; MSD; SERVIER
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen
 
Francesco Giuliani
No Relationships to Disclose
 
Guglielmo Nasti
No Relationships to Disclose
 
Vincenzo Montesarchio
No Relationships to Disclose
 
Giuseppe Santabarbara
No Relationships to Disclose
 
Silvana Leo
No Relationships to Disclose
 
Umberto Malapelle
Employment - Roche (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Diaceutics; GlaxoSmithKline; Lilly; Merck; MSD; Roche; Thermo Fisher Scientific
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Diaceutics; GlaxoSmithKline; Lilly; Merck; MSD; Roche; Thermo Fisher Scientific
 
Alfonso De Stefano
No Relationships to Disclose
 
Gerardo Rosati
No Relationships to Disclose
 
Ivan Lolli
No Relationships to Disclose
 
Emiliano Tamburini
No Relationships to Disclose
 
Alfredo Colombo
No Relationships to Disclose
 
Daniele Santini
No Relationships to Disclose
 
Lucrezia Silvestro
No Relationships to Disclose
 
Alessandra Leone
No Relationships to Disclose
 
Carlo Vitagliano
No Relationships to Disclose
 
Giancarlo Troncone
No Relationships to Disclose
 
Alberto F. Sobrero
Consulting or Advisory Role - Amgen; Bayer; BMS; Celgene; Hutchmed; Menarini; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Roche
 
Diana Giannarelli
Consulting or Advisory Role - MSD
 
Alfredo Budillon
No Relationships to Disclose